TrialAnnals of oncology : official journal of the European Society for Medical Oncology2019

Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial.

N W Clarke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.